Condition
Cardiomyopathy, Primary
Total Trials
2
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Plasma Biomarker Levels
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Active Not Recruiting1
Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Plasma Biomarker Levels1
Active Sponsors
- NHS Greater Glasgow and Clyde1
- University of Glasgow1
- St. Jude Children's Research Hospital1
- Roche Diagnostics GmbH1
Top Investigators
St. Jude Children's Research Hospital
Related Conditions
- Genetic Predisposition1
- Cardiomyopathies1
- Childhood Cancer1